Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced the close of a $215 million Series B ...
A widely recognized and trusted advisor, Ian Ziskin’s global business leadership experience includes CHRO and other senior roles with three Fortune 100 corporations – Northrop Grumman, Qwest ...
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions (“TSS”), Titanium Technologies ...